Valeant Pharmaceuticals International Inc. said it has proposed a deal with its lenders to avoid a default by extending its filing deadlines and restricting the company from making some acquisitions.
from WSJ.com: US Business http://ift.tt/1SmiCSL
via IFTTT
No comments:
Post a Comment